257 related articles for article (PubMed ID: 3000291)
1. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA
Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with 5-ethyl-2'-deoxyuridine on herpes simplex virus encephalitis in normal and immunosuppressed mice.
Davis WB; Oakes JE; Taylor JA
Antimicrob Agents Chemother; 1978 Nov; 14(5):743-8. PubMed ID: 215081
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
7. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy.
Cheng YC; Grill S; Ruth J; Bergstrom DE
Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181
[TBL] [Abstract][Full Text] [Related]
8. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
[TBL] [Abstract][Full Text] [Related]
9. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.
De Clercq E; Rosenwirth B
Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841
[TBL] [Abstract][Full Text] [Related]
10. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
11. Antiviral effect of chinonin against herpes simplex virus.
Jiang J; Li S; Li M; Xiang J
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):521-4. PubMed ID: 15641710
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.
Teh CZ; Sacks SL
Antimicrob Agents Chemother; 1983 May; 23(5):637-40. PubMed ID: 6307130
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Freeman DJ; Sacks SL; De Clercq E; Spruance SL
Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
[TBL] [Abstract][Full Text] [Related]
14. Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs.
Spruance SL; Freeman DJ; Sheth NV
Antimicrob Agents Chemother; 1985 Jul; 28(1):103-6. PubMed ID: 4037770
[TBL] [Abstract][Full Text] [Related]
15. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
[TBL] [Abstract][Full Text] [Related]
17. Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice.
Sarisky RT; Bartus HR; Dennis SA; Quail MR; Nguyen TT; Wittrock RJ; Halsey WS; Bacon TH; Leary JJ; Sutton D
BMC Infect Dis; 2001; 1():24. PubMed ID: 11749671
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
[TBL] [Abstract][Full Text] [Related]
19. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
20. Specific phosphorylation of 5-ethyl-2'-deoxyuridine by herpes simplex virus-infected cells and incorporation into viral DNA.
De Clercq E; Bernaerts R
J Biol Chem; 1987 Nov; 262(31):14905-11. PubMed ID: 2822705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]